Companies
Zhongke Aoge Biotech
has kept a gene-edited pig kidney functioning in a non-human primate recipient for more than 600 days in collaboration with Huazhong University of Science and Technology's Tongji Hospital,…
- Country
- China
xenotransplant
kidney
cn
Coverage
| CN | EU | US | |
|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Over 200 million RMB in A3 round funding (August 2026) | clonorgan.com · shenlannews.com · toutiao.com · vbdata.cn |
| Capacity | 3,000 pigs per year at Neijiang base | sichuan.scol.com.cn |
| Production site | Neijiang (DPF-level medical donor pig breeding base) | sichuan.scol.com.cn · vbdata.cn |
| Production site | Hebei Zhuozhou (DPF medical donor pig cultivation platform) | vbdata.cn |
| Regulatory approval | Registered for clinical research following May 2026 guidelines medium confidence | shenlannews.com · vbdata.cn |
Independent sources: clonorgan.com · shenlannews.com · sichuan.scol.com.cn · toutiao.com · vbdata.cn
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Xenotransplantation | regenerative-personalized | High | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.